Last reviewed · How we verify
Pulmonary Thromboembolism Prevention
Approved treatments
- Heparin Sodium In Plastic Container · Merck & Co.
Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots. - Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa. - Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary Thromboembolism Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary Thromboembolism Prevention treatment landscape brief
- Pulmonary Thromboembolism Prevention treatment updates RSS
Frequently asked questions about Pulmonary Thromboembolism Prevention
What drugs treat Pulmonary Thromboembolism Prevention?
Tracked treatments include Heparin Sodium In Plastic Container, Coumadin.
What is the treatment for Pulmonary Thromboembolism Prevention?
Standard treatment for Pulmonary Thromboembolism Prevention includes Heparin Sodium In Plastic Container, Coumadin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pulmonary Thromboembolism Prevention patent cliff · Pulmonary Thromboembolism Prevention CI report
- Treatment: Heparin Sodium In Plastic Container · Merck & Co.
- Treatment: Heparin Sodium In Plastic Container · Fresenius Kabi
- Treatment: Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing